Puberty, Diabetes, and the Kidneys, When Eustress Becomes Distress (PANTHER Study)

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age8-14
SponsorPetter Bjornstad

About this trial

Early diabetic kidney disease (DKD) occurs in 50-70% of youth with type 2 diabetes (T2D) and confers high lifetime risk of dialysis and premature death. Youth-onset T2D typically manifests during or shortly after puberty in adolescents with obesity. Epidemiological data implicate puberty as an accelerator of kidney disease in youth with obesity and diabetes and the investigators posit that the link between puberty and T2D-onset may explain the high burden of DKD in youth-onset T2D. A better understanding of the impact of puberty on kidney health is needed to promote preservation of native kidney function, especially in youth with T2D.

Eligibility criteria

Qualifiers

HbA1c ≥6.0% for untreated high-risk group

BMI ≥ 85th %ile for high-risk group

Normal HbA1c ≤5.6% for control group

Type 1 diabetes (T1D) Antibody negative

Disqualifiers

History of Chronic kidney disease (CKD) or acute kidney injury (AKI)

Metabolic disorder prohibiting safe fasting

Iodine or penicillin allergy

Pregnancy

Trial design

Treatments tested in this trial

  • Aminohippurate Sodium Inj 20%
  • Iohexol Inj 300 MG/ML
  • Dextran 40

Treatment groups

100 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Petter Bjornstad

Lead sponsor

Seattle Children's Hospital

Sponsor institution

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Collaborator

Seattle Children's Hospital

Collaborator

University of Colorado, Denver

Collaborator